Showing results (331-340 of 365) with videos related to
Sort By:
Pageof 37
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|July 18, 2024
Long term outcome in non-multiple sclerosis paediatric acquired demyelinating syndromesEvangeline Wassmer, Charly Billaud, Michael Absoud, et al.Plos One|January 6, 2021
Factors associated with self-reported burnout level in allied healthcare professionals in a tertiary hospital in SingaporeYao Hao Teo, Jordan Thet Ke Xu, Cowan Ho, et al.JAMA Neurology|January 7, 2018
Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseYael Hacohen, Yu Yi Wong, Christian Lechner, et al.The Lancet. Haematology|July 23, 2019
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trialSaad Zafar Usmani, Fredrik Schjesvold, Albert Oriol, et al.Journal of Biomedical Materials Research. Part B, Applied Biomaterials|September 24, 2017
Immobilization of vitronectin-binding heparan sulfates onto surfaces to support human pluripotent stem cellsLynn Yap, Sadasivam Murali, Gajadhar Bhakta, et al.Cancer Immunology, Immunotherapy : CII|March 17, 2022
Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptorsMukul Prasad, Sashigala Ponnalagu, Qun Zeng, et al.EMBO Molecular Medicine|December 8, 2011
Mycolic acids as diagnostic markers for tuberculosis case detection in humans and drug efficacy in miceGuanghou Shui, Anne K Bendt, Ignasius A Jappar, et al.Bone Marrow Transplantation|April 29, 2021
The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed by a melphalan autograftMatthew J Rees, Peter Mollee, Jun Yen Ng, et al.Neurology(R) Neuroimmunology & Neuroinflammation|August 1, 2020
Treatment and outcome of aquaporin-4 antibody-positive NMOSD: A multinational pediatric studyRenata Barbosa Paolilo, Yael Hacohen, Elise Yazbeck, et al.Nature Communications|May 1, 2020
Targeting codon 158 p53-mutant cancers via the induction of p53 acetylationLi Ren Kong, Richard Weijie Ong, Tuan Zea Tan, et al.Pageof 37